Nuveen Asset Management, LLC Soleno Therapeutics Inc Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$0.97 - $1.32 $146,296 - $199,083	-150,821 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.24 - $3.3 $31,958 - $85,050	-25,773 Reduced 14.59%	150,821 $191,000
Q4 2020 Feb 16, 2021	BUY	$1.61 - $2.23 $79,704 - $110,398	49,506 Added 38.95%	176,594 $341,000
Q3 2020 Nov 16, 2020	BUY	$1.71 - $2.51 $46,192 - $67,802	27,013 Added 26.99%	127,088 $319,000
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.23 $177,132 - $423,317	100,075 New	100,075 $223,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $441M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.